Emerging drugs and targets for Parkinsons disease
Now is an important time for medicinal chemistry. This week Professor Giovanna Mallucci’s team at the University of Leicester reported landmark findings for developing future treatments of neurodegenerative diseases, such as Alzheimer’s, Huntingdon’s and Parkinson’s. Research into these diseases is a crucial part of coping with aging populations. The Royal Society of Chemistry’s timely publication Emerging Drugs and Targets for Parkinson’s Disease edited by Ana Martinez and Carmen Gil, reviews state of the art treatments for Parkinson’s Disease and assesses promising future treatments.
Another Royal Society of Chemistry title published this summer is Supramolecular Systems in Biomedical Fields edited by Hans-Jörg Schneider. Supramolecular chemistry is an increasingly important field for drug delivery systems, as shown by Ran Lin and coworkers in a ChemComm article in April this year.
More new, topical titles recently published include Biotherapeutics edited by Lyn H Jones and Andrew J McKnight, New Applications of NMR in Drug Discovery and Development edited by Leoncio Garrido and Nicolau Beckmann, and Chromatographic Methods in Metabolomics edited by Tuulia Hyotylainen and Susanne Wiedmer.
If you have an idea for a book or you would like to find out more about the RSC Drug Discovery, Issues in Toxicology or RSC Metallobiology Series please contact the medicinal chemistry Commissioning Editor, Cara Sutton.
